Proposed Data Collection Submitted for Public Comment and Recommendations

Issuing agencies

Abstract

The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies the opportunity to comment on a continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled Evaluation of the Division of Overdose Prevention Technical Assistance Center. This data collection activity is focused on comprehensive and interdisciplinary opioid overdose prevention efforts in 90 jurisdictions.

Full Text

<html>
<head>
<title>Federal Register, Volume 91 Issue 216 (Tuesday, November 10, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 216 (Tuesday, November 10, 2026)]
[Notices]
[Pages 72540-72541]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-22881]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-27-1355; Docket No. CDC-2026-1751]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public burden and maximize the 
utility of government information, invites the general public and other 
federal agencies the opportunity to comment on a continuing information 
collection, as required by the Paperwork Reduction Act of 1995. This 
notice invites comment on a proposed information collection project 
titled Evaluation of the Division of Overdose Prevention Technical 
Assistance Center. This data collection activity is focused on 
comprehensive and interdisciplinary opioid overdose prevention efforts 
in 90 jurisdictions.

DATES: CDC must receive written comments on or before January 11, 2027.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2026-
1751 by either of the following methods:
    <bullet> Federal eRulemaking Portal: <a href="http://www.regulations.gov">www.regulations.gov</a>. Follow 
the instructions for submitting comments.
    <bullet> Mail: Jeffrey M. Zirger, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS H21-8, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without change, all relevant comments 
to <a href="http://www.regulations.gov">www.regulations.gov</a>.
    Please note: Submit all comments through the Federal eRulemaking 
portal (<a href="http://www.regulations.gov">www.regulations.gov</a>) or by U.S. mail to the address listed 
above.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact Jeffrey M. Zirger, Information Collection 
Review Office, Centers for Disease Control and Prevention, 1600 Clifton 
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570; 
Email: <a href="/cdn-cgi/l/email-protection#c7a8aaa587a4a3a4e9a0a8b1"><span class="__cf_email__" data-cfemail="016e6c63416265622f666e77">[email&#160;protected]</span></a>.

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to the OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected;
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses; and
    5. Assess information collection costs.

Proposed Project

    Evaluation of the Division of Overdose Prevention Technical 
Assistance Center (OMB Control No. 0920-1355, Exp. 12/31/2027)--
Extension--National Center for Injury Prevention and Control (NCIPC), 
Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    This Extension is being submitted to support the evaluation of 
technical assistance (TA) provided for the Overdose Data to Action 
(OD2A) in States (S) and OD2A: Limiting Overdose through Collaborative 
Actions in Localities (LOCAL) programs. OD2A-S and OD2A: LOCAL are 
cooperative agreements funded in 2023 to focus on comprehensive and 
interdisciplinary opioid overdose prevention efforts in 90

[[Page 72541]]

jurisdictions, including 49 state health departments, 39 localities, 
Puerto Rico, and Washington DC. Each program consists of two required 
components; a surveillance component and a prevention component. OD2A 
recipients implement a combination of activities across nine state 
strategies and eight local strategies within these components to gain 
access to high quality, complete, and timelier data on opioid 
prescribing and overdoses, and to use those data to inform prevention 
and response efforts in their jurisdictions.
    In the previously approved iteration of this information collection 
request (ICR), the information collected surrounding OD2A recipient 
feedback on their experiences receiving TA has been invaluable in 
improving TA delivery. The feedback provided in the original data 
collection instruments was also used to improve the TA Strategy of OD2A 
at large. Further information gathering will enhance TA perspectives 
and needs to utilize the Division of Overdose Prevention (DOP) TA 
Center resource effectively and responsibly.
    Training and TA is essential to building knowledge and 
strengthening the capacity of recipients to implement and evaluate OD2A 
program strategies. CDC developed and deployed a TA hub (hereafter 
referred to as the DOP TA Center) to deliver comprehensive technical 
assistance and training to support the successful implementation and 
evaluation of surveillance and prevention activities. The DOP TA Center 
is designed to enhance the efficiency, coordination, and effectiveness 
of TA efforts by streamlining and centralizing the provision of 
overdose surveillance and prevention TA. TA to OD2A recipients is 
divided into four different levels with multiple modes of TA delivery 
and involves a wide range of TA providers including CDC staff, internal 
and external subject matter experts (SMEs) and program partners as well 
as Tanaq and ICF staff. The TA levels are used to direct the process 
for engaging stakeholders to support program recipients and triage 
appropriate resources to support their needs.
    This package aims to extend approval for the instruments previously 
approved. CDC requests OMB approval for an estimated 388 annual burden 
hours. There are no costs to respondents other than their time to 
participate.

                                                            Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                                             Number of    Average burden
              Type of respondents                               Form name                    Number of     responses per   per response    Total burden
                                                                                            respondents     respondent      (in hours)      (in hours)
--------------------------------------------------------------------------------------------------------------------------------------------------------
OD2A (OD2A in States and OD2A: LOCAL)            TA Feedback Form Individual............             618               2            5/60             103
 Recipients.
                                                 TA Feedback Form Universal.............             617               2            5/60             103
                                                 Annual Technical Assistance Survey.....             162               1           10/60              27
                                                 Implementation Feedback Survey.........              18               1           15/60               5
                                                 Email invitation for Annual Survey.....             900               1            2/60              30
                                                 Focus Groups Email invitation..........             600               1            2/60              20
                                                 Focus Group Session....................             100               1               1             100
                                                                                         ---------------------------------------------------------------
    Total......................................  .......................................  ..............  ..............  ..............             388
--------------------------------------------------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health 
Ethics and Regulations, Office of Science, Centers for Disease Control 
and Prevention.
[FR Doc. 2026-22881 Filed 11-9-26; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>